C. Moroz

666 total citations
47 papers, 541 citations indexed

About

C. Moroz is a scholar working on Molecular Biology, Immunology and Obstetrics and Gynecology. According to data from OpenAlex, C. Moroz has authored 47 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Obstetrics and Gynecology. Recurrent topics in C. Moroz's work include Pregnancy and preeclampsia studies (12 papers), RNA modifications and cancer (9 papers) and Reproductive System and Pregnancy (8 papers). C. Moroz is often cited by papers focused on Pregnancy and preeclampsia studies (12 papers), RNA modifications and cancer (9 papers) and Reproductive System and Pregnancy (8 papers). C. Moroz collaborates with scholars based in Israel, United Kingdom and Austria. C. Moroz's co-authors include Bracha Ramot, Nitza Lahat, Ziva Weisman, S. Bar‐Yehuda, Zvi Bentwich, Alexander Kalinkovich, Miriam Biniaminov, Hanna Bessler, Lea Sirota and Mati Shaklai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gut and The Journal of Urology.

In The Last Decade

C. Moroz

44 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Moroz Israel	11	164	140	96	83	71	47	541
M Naiem United Arab Emirates	9	374 2.3×	152 1.1×	65 0.7×	45 0.5×	40 0.6×	15	711
Tünde Hidvégi Hungary	10	318 1.9×	103 0.7×	108 1.1×	12 0.1×	106 1.5×	13	592
Lyna Zhang United Kingdom	15	230 1.4×	241 1.7×	43 0.4×	86 1.0×	275 3.9×	17	905
Xiucai Xu China	17	210 1.3×	191 1.4×	121 1.3×	21 0.3×	261 3.7×	28	755
Sami Remadi Switzerland	16	133 0.8×	248 1.8×	19 0.2×	22 0.3×	144 2.0×	50	787
Emanuele Marchi United Kingdom	15	350 2.1×	242 1.7×	100 1.0×	113 1.4×	146 2.1×	28	887
Awadh A. Binhazim United States	14	70 0.4×	149 1.1×	21 0.2×	19 0.2×	77 1.1×	23	444
Edward D. Crum United States	13	176 1.1×	65 0.5×	37 0.4×	10 0.1×	24 0.3×	28	448
Anders Waage Norway	8	164 1.0×	105 0.8×	102 1.1×	45 0.5×	74 1.0×	10	379
H O Madsen Denmark	6	658 4.0×	114 0.8×	84 0.9×	18 0.2×	119 1.7×	9	844

Countries citing papers authored by C. Moroz

Since Specialization

Citations

This map shows the geographic impact of C. Moroz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Moroz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Moroz more than expected).

Fields of papers citing papers by C. Moroz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Moroz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Moroz. The network helps show where C. Moroz may publish in the future.

Co-authorship network of co-authors of C. Moroz

This figure shows the co-authorship network connecting the top 25 collaborators of C. Moroz. A scholar is included among the top collaborators of C. Moroz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Moroz. C. Moroz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jauniaux, Eric, R. Maymon, Natalie Greenwold, J. Hustin, & C. Moroz. (2000). Diminished Expression of Placental Isoferritin p43 Component in First Trimester Abnormal Pregnancies. Placenta. 21(4). 408–411. 6 indexed citations

Moroz, C., et al.. (2000). Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component. Prenatal Diagnosis. 20(5). 395–399. 4 indexed citations

Rosén, Anders, E. Hafner, R. Obwegeser, et al.. (1999). Früherkennung fetaler Wachstumsretardierung durch Bestimmung des plazentaren Isoferritins. Gyn�kologisch-geburtshilfliche Rundschau. 39(4). 195–198.

Maymon, Ron, E. Jauniaux, Jacob Bar, & C. Moroz. (1998). Maternal Serum Placental Isoferritin Levels in Pregnant Women with Abnormal Uterine Artery Doppler Velocemitry. American Journal of Perinatology. 15(11). 607–612. 2 indexed citations

Maymon, R., Jacob Bar, D. Sherman, & C. Moroz. (1998). Placental Isoferritin Levels in Pregnant Patients with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome. American Journal of Reproductive Immunology. 40(2). 95–101. 6 indexed citations

Maymon, Ron, et al.. (1998). Comparison of placental isoferritin levels in maternal serum and coelomic and amniotic fluids during first trimester human gestation. Human Reproduction. 13(4). 1044–1046. 2 indexed citations

Moroz, C., Hanna Bessler, Moshe Katz, et al.. (1997). Elevated serum ferritin level in acute myocardial infarction. Biomedicine & Pharmacotherapy. 51(3). 126–130. 12 indexed citations

Fisch, Benjamin, et al.. (1996). Placental isoferritin as a marker of early abortion in pregnancies induced by in vitro fertilization. Placenta. 17(4). 247–251. 6 indexed citations

Zahavi, Izhar, et al.. (1996). Antimitochondrial Antibodies after Acute Myocardial Infarction. Cardiology. 87(1). 67–70. 4 indexed citations

10.

Weinraub, Z., et al.. (1995). Placental isoferritin levels during first trimester of normal and complete molar gestations. Placenta. 16(5). 455–460. 6 indexed citations

11.

Bukovsky, Ian, et al.. (1995). Pregnancy: Placental isoferritin patterns during normal first trimester and tubal gestations. Human Reproduction. 10(9). 2445–2447. 7 indexed citations

12.

Sedlák, J, et al.. (1995). Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines. Cancer Letters. 94(1). 101–106. 5 indexed citations

13.

Dinari, Gabriel, et al.. (1991). Placental ferritin in coeliac disease: relation to clinical stage, origin, and possible role in the pathogenesis of malignancy.. Gut. 32(9). 999–1003. 6 indexed citations

14.

Rosén, Harald, Dov Flex, M. Stierer, & C. Moroz. (1991). Monoclonal antibody CM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer. Cancer Letters. 59(2). 145–151. 12 indexed citations

15.

Moroz, C., Yaël C. Cohen, Javad Khodadadi, et al.. (1989). Radioimmunodetection of Tumors with Monoclonal Antiplacental Ferritin Antibody: Preliminary Results. Oncology. 46(1). 35–39. 2 indexed citations

16.

Moroz, C., et al.. (1989). T-cell mitogenesis stimulates the synthesis of a mRNA species coding for a 43-kDa peptide reactive with CM-H-9, a monoclonal antibody specific for placental isoferritin.. Proceedings of the National Academy of Sciences. 86(9). 3282–3285. 10 indexed citations

17.

Moroz, C., Hanna Bessler, Yoav Lurie, & Mati Shaklai. (1987). New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies.. PubMed. 15(3). 258–62. 34 indexed citations

18.

Moroz, C., et al.. (1978). The significance of ferritin in malignant diseases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(4). 203–6. 17 indexed citations

19.

Moroz, C. & André de Vries. (1971). Vipera palestinae antivenin.. 1. 37–42. 1 indexed citations

20.

Moroz, C., À. de Vries, & N Goldblum. (1966). Preparation of horse antiserum against Echis colorata (Gunther) venom and determination of its capacity to neutralize the toxic, afibrinogenemic and thrombocytopenic actions of Echis colorata and Echis carinata venoms.. PubMed. 110(2). 276–82. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact